IMMUcan consortium: Focus on the first results of the non-small cell lung cancer (NSCLC) cohort

被引：0

作者：

Morfouace, M. ^{[1
]}

Schulz, D. ^{[2
]}

Eling, N. ^{[3
]}

Marzetta, F. ^{[4
]}

Loizides, C. ^{[5
]}

Rusakiewicz, S. ^{[6
]}

Liechti, R. ^{[4
]}

Hong, H. S. ^{[7
]}

Robert, M-S. ^{[8
]}

Bironzo, P. ^{[9
]}

Cufer, T. ^{[10
]}

Oselin, K. ^{[11
]}

Cloarec, N. ^{[12
]}

Oliveira, J. ^{[13
]}

Bodenmiller, B. ^{[14
]}

Besse, B. ^{[15
]}

机构：

[1] Merck KGaA Headquarters Merck Grp, RU Oncol Dept, Darmstadt, Germany

[2] UZH Univ Zurich, Oncol Dept, Irchel Campus, Zurich, Switzerland

[3] UZH Univ Zurich, Oncol Dept, Competence Ctr Personalized Med CC PM, Zurich, Switzerland

[4] SIB Swiss Inst Bioinformat, Oncol Dept, Lausanne, Switzerland

[5] EORTC AISBL IVZW European Org Res & Treatment Can, Oncol Dept, Brussels, Belgium

[6] Ludwig Canc Ctr Univ Lausanne CHUV, Oncol Dept CTE, Lausanne, Switzerland

[7] Merck KGaA, TIP Immunooncol Dept, Darmstadt, Germany

[8] EORTC AISBL IVZW European Org Res & Treatment Can, Project Direct, Brussels, Belgium

[9] Azienda Osped Univ San Luigi Gonzaga, Oncol Dept, Orbassano, Italy

[10] Univ Ljubljana, Med Oncol Dept, Fac Med, Ljubljana, Slovenia

[11] North Estonia Med Ctr Fdn SA Pohja Eesti Regionaa, Chemotherapy Dept, Tallinn, Estonia

[12] CH Henri Duffaut, Oncol, Avignon, France

[13] EPE IPO Porto, Inst Portugues Oncol Porto Francisco Gentil, Oncol Dept, Porto, Portugal

[14] UZH Univ Zurich, Inst Mol Life Sci, Irchel Campus, Zurich, Switzerland

[15] Inst Gustave Roussy, Canc Med Dept, Villejuif, France

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

基金：

欧盟地平线“2020”;

关键词：

D O I：

10.1016/j.annonc.2023.09.1294

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2266P

引用

页码：S1164 / S1164

页数：1

共 50 条

[1] NON-SMALL CELL LUNG CANCER (NSCLC) GENOTYPING IN A BRAZILIAN COHORT
Melo, Andreia C. D.
Inada, Haynna K. P.
Barros, Milton
Terra, Simone B. S. P.
Ligorio, Claudia
Sugawara, Emiko
Small, Isabele A.
Soares, Fernando A.
Cappuzzo, Federico
Takeuchi, Kengo
Ferreira, Carlos G. M.
Sternberg, Cinthya
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1003 - S1004
[2] β-catenin in non-small cell lung cancer (NSCLC)
Swinson, DEB
Lolljee, J
Edwards, JG
Jones, JL
Cox, G
Richardson, D
O'Byrne, KJ
BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
[3] Micrometastases in non-small cell lung cancer (NSCLC)
Passlick, B
LUNG CANCER, 2001, 34 : S25 - S29
[4] Immunotherapy for non-small cell lung cancer (NSCLC)
Frost, Nikolaj
Reck, Martin
INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
[5] Genotyping Non-Small Cell Lung Cancer (NSCLC)
Delia Campos-Parra, Alma
Cruz-Rico, Graciela
Arrieta, Oscar
GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
[6] Treatment of non-small cell lung cancer (NSCLC)
Zarogoulidis, Konstantinos
Zarogoulidis, Paul
Darwiche, Kaid
Boutsikou, Efimia
Machairiotis, Nikolaos
Tsakiridis, Kosmas
Katsikogiannis, Nikolaos
Kougioumtzi, Ioanna
Karapantzos, Ilias
Huang, Haidong
Spyratos, Dionysios
JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
[7] Eicosanoids in non-small cell lung cancer (NSCLC)
Johnson, D. H.
Horn, L.
Zhao, Z.
Milne, G.
Morrow, J.
Sandler, A.
Shyr, Y.
Carbone, D. P.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[8] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
Christian Manegold
Petr Zatloukal
Kurt Krejcy
Johannes Blatter
Investigational New Drugs, 2000, 18 : 29 - 42
[9] BRCAness in non-small cell lung cancer (NSCLC).
Waqar, Saiama Naheed
Devarakonda, Siddhartha H. K.
Michel, Loren S.
Maggi, Leonard B.
Watson, Mark
Guebert, Kalin
Carpenter, Danielle
Sleckman, Barry P.
Govindan, Ramaswamy
Morgensztern, Daniel
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[10] Gemcitabine in non-small cell lung cancer (NSCLC)
Manegold, C
Zatloukal, P
Krejcy, K
Blatter, J
INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42

← 1 2 3 4 5 →